Arterys has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Arterys Cardio DL application. Arterys Cardio DL is the first technology to be cleared by the FDA that leverages cloud computing and deep learning in a clinical setting.
January 9, 2017 β The U.S. Food and Drug Administration (FDA) issued a safety communication today concerning patient ...
January 6, 2017 β SentreHeart Inc. announced that it has completed the Stage I enrollment milestone in the aMAZE Trial ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
ITN and DAIC Editor Dave Fornell takes a tour of some of the most innovative new technologies being displayed on the ...
The RECHORD trial allows cardiovascular surgeons to replace damaged string-like tendons, called chordae, through a small incision while the heart is beating. The trial compares outcomes from this minimally invasive procedure to traditional open-heart mitral valve surgery, which requires the chest to be cracked. Specialized imaging is used to place the artificial chordae. PinnacleHealth is one of only 20 sites in the nation and the only hospital in Pennsylvania selected to participate in the trial. Up to 450 patients will be enrolled into the randomized trial.
Toshiba Medical announced in November that its Vantage Titan 1.5T/cS Edition magnetic resonance imaging (MRI) system with M-Power V3.6 software received U.S. Food and Drug Administration (FDA) clearance at the 2016 annual meeting of the Radiological Society of North America (RSNA). The new system retains all the patient-friendly features of the Vantage Titan 1.5T MR with added technology to simplify complex cardiac exams.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
January 5, 2017 β Whether patients with mechanical heart valves and stents must take blood thinners depends on how ...
Too little sleep takes a toll on your heart, according to a new study presented at the 2016 annual meeting of the Radiological Society of North America (RSNA), Nov. 27-Dec. 1 in Chicago.
January 5, 2017 β A new report published by Allied Market Research forecasts that the global thrombectomy devices market ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The American Society of Echocardiography (ASE) is in the midst of Echovation Challenge 2017, a competition for its members, and the medical and scientific community at large, to develop innovative solutions in cardiovascular ultrasound technology.
January 5, 2017 β Reacting to a critical shortage of electrophysiology (EP) lab technicians and nurses who treat heart ...
At RSNA 2016, Siemens Healthineers unveiled its groundbreaking Compressed Sensing technology, which overcomes a major ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
January 5, 2017 β Working in concert, the American Society of Nuclear Cardiology (ASNC), the Intersocietal Accreditation ...
January 5, 2017 β Abbott announced it completed the acquisition of St. Jude Medical Inc. The transaction provides Abbott ...
In a study published online by JAMA Cardiology, researchers from Stanford University assessed the feasibility of measuring physical activity, fitness and sleep from smartphones. The goal was to gain insight into activity patterns associated with life satisfaction and self-reported disease.